Search company, investor...

Founded Year

2018

Stage

Line of Credit | Alive

Total Raised

$65.83M

Last Raised

$50M | 3 yrs ago

About Novaremed

Novaremed is a clinical-stage Swiss biopharmaceutical company developing an orally active, small molecule (NRD.E1) to treat Diabetic Neuropathic Pain.

Headquarters Location

Teichgaesslein 9

Basel, 4058,

Switzerland

+41 61 317 93 26

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Novaremed Patents

Novaremed has filed 5 patents.

The 3 most popular patent topics include:

  • Amines
  • Benzamides
  • Enantiopure drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/30/2014

7/5/2016

Stereochemistry, Amines, Benzamides, Piperidines, Enantiopure drugs

Grant

Application Date

5/30/2014

Grant Date

7/5/2016

Title

Related Topics

Stereochemistry, Amines, Benzamides, Piperidines, Enantiopure drugs

Status

Grant

Latest Novaremed News

Neurofront picks up option to in-license Novaremed non-opioid neuropathic pain drug

Jul 26, 2022

July 26, 2022 Neurofront Therapeutics Ltd. has picked up an option to acquire exclusive Asia rights to a phase II non-opioid drug from Novaremed AG. Under terms of the deal, Novaremed is eligible to receive more than $130 million in option and exercise fees as well as development, regulatory and sales milestone payments plus royalties on net sales. Shanghai, China-based Neurofront obtained rights to develop and commercialize the candidate in mainland China, Hong Kong, Macau, Taiwan and Singapore.

Novaremed Frequently Asked Questions (FAQ)

  • When was Novaremed founded?

    Novaremed was founded in 2018.

  • Where is Novaremed's headquarters?

    Novaremed's headquarters is located at Teichgaesslein 9, Basel.

  • What is Novaremed's latest funding round?

    Novaremed's latest funding round is Line of Credit.

  • How much did Novaremed raise?

    Novaremed raised a total of $65.83M.

  • Who are the investors of Novaremed?

    Investors of Novaremed include Global Emerging Markets.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.